Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.
Third Party Pharmaceuticals, also known as Contract Manufacturing in the pharmaceutical industry, is a business model in which a marketing company sells medicines under its own brand name while the actual manufacturing is carried out by another licensed and certified pharmaceutical manufacturer. In this arrangement, the marketing company does not need to set up its own manufacturing plant, invest in expensive machinery, or hire technical production staff. Instead, it collaborates with a manufacturer that already has the necessary infrastructure, regulatory approvals, and certifications such as WHO-GMP and other required drug authority licenses.
Under third party manufacturing, the marketing company selects the product composition, decides the brand name, approves the packaging design, and places the production order with the manufacturer. The manufacturing company produces the medicine according to approved standards and regulatory guidelines. On the final product packaging, the manufacturer’s name appears under “Manufactured by,” while the marketing company’s name is mentioned under “Marketed by.”
This model is widely popular in countries like India because it allows small and medium-sized pharmaceutical companies to enter the market with relatively low investment and minimal operational risk. The manufacturer handles production, quality control, batch testing, and compliance with drug regulations, while the marketing company focuses on branding, promotion, sales, and distribution. Overall, Third Party Pharmaceutical Manufacturing is considered a cost-effective, efficient, and scalable business strategy that enables companies to expand their product portfolio and grow in the competitive pharmaceutical market without owning a manufacturing facility.